The invention provides biaryl meta-pyrimidine compounds having the general structure (A). The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Jak kinase family, and various other specific receptor and non-receptor kinases.
The invention provides biaryl meta-pyrimidine compounds having the general structure (A). The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Jak kinase family, and various other specific receptor and non-receptor kinases.
Substituted 1-aminoalkylamino-4-aryloxypiperidines, a process for their preparation, intermediates thereof, and their use as medicaments
申请人:HOECHST-ROUSSEL
PHARMACEUTICALS INCORPORATED
公开号:EP0158283A2
公开(公告)日:1985-10-16
The present invention relates to substituted-1-amino- alkylamino-4-aryloxypiperidines of the formula
where X is hydrogen, loweralkyl, CF3, acetyl or halogen; n is 1 or 2; R, is H2 or oxygen; R2 is H, loweralkyl or benzyl; and R3 is oxygen or -O-CH2CH2-O-, which are useful as analgesic agents, a process for their preparation and intermediate compounds therefor.